“…Twenty-one studies were conducted in clinical samples [four in First Episode of Psychosis (FEP) or early psychosis patients (Evans, Reid, Preston, Palmier-Claus, & Sellwood, 2015; Morgan et al, 2014; Peach, Alvarez-Jimenez, Cropper, Sun, & Bendall, 2019; Sun et al, 2018), three in Ultra High Risk (UHR) patients (Appiah-Kusi et al, 2017; McDonnell, Stahl, Day, McGuire, & Valmaggia, 2018; Thompson et al, 2016), 14 in non-FEP patients (Cancel et al, 2015; Chatziioannidis et al, 2019; Choi et al, 2015; Hardy et al, 2016; Isvoranu et al, 2017; Perona-Garcelán et al, 2012; Quidé, O'Reilly, Watkeys, Carr, & Green, 2018; Schalinski et al, 2019; Steenkamp, Weijers, Gerrmann, Eurelings-Bontekoe, & Selten, 2019; Styła, Stolarski, & Szymanowska, 2019; Van Dam, Korver-Nieberg, Velthorst, Meijer, & de Haan, 2014; Varese, Barkus, & Bentall, 2012a; Weijers et al, 2018; Wickham & Bentall, 2016) 27 in GP (Ashford, Ashcroft, & Maguire, 2012; Bortolon & Raffard, 2018; Bortolon, Seillé, & Raffard, 2017; Boyda & McFeeters, 2015; Boyda, McFeeters, Dhingra, & Rhoden, 2018; Cole, Newman-Taylor, & Kennedy, 2016; Fisher, Appiah-Kusi, & Grant, 2012, 2013; Gawęda, Göritz, & Moritz, 2019; Gibson, Reeves, Cooper, Olino, & Ellman, 2019; Goodall, Rush, Grünwald, Darling, & Tiliopoulos, 2015; Jaya, Ascone, & Lincoln, 2017; Lincoln, Marin, & Jaya, 2017; Marwaha & Bebbington, 2015; Marwaha, Broome, Bebbington, Kuipers, & Freeman, 2014; McCarthy-Jones, 2018; Mętel et al, 2020; Murphy, Murphy, & Shevlin, 2015; Perona-Garcelán et al, 2014; Pinto-Gouveia, Matos, Castilho, & Xavier, 2014; Rössler, Ajdacic-Gross, Rodgers, Haker, & Müller, 2016; Sheinbaum, Kwapil, & Barrantes-Vidal, 2014; Shevlin, McElroy, & Murphy, 2015; Sitko, Bentall, Shevlin, O'Sullivan, & Sellwood, 2014; van Nierop et al, 2014; Wolke, Lereya, Fisher, Lewis, & Zammit, 2014; Yamasaki et al, 2016)]. Our review included 82 352 subjects from the GP and 3189 subjects from clinical studies.…”